Pentax Medical Europe today said it received CE mark approval for its single-use bronchoscope and is set to launch the device in Europe later this year.
The Tokyo-based company designed the PulmoOne single-use bronchoscope to mimic the ergonomics of a reusable bronchoscope with similar scope handling and tip angulation that requires no change in physician technique.
PulmoOne has a large working channel that provides up to 50% more suction power. It comes in sterile packaging that makes it ready to use at any time.
“The single-use bronchoscope was developed in close collaboration with physicians to offer them a solution based on their needs. As part of our Triple Aim program, we continually improve patient outcomes by offering evidence-based solutions,” the head of R&D at Pentax Medical Wolfgang Mayer said in a news release.
Pentax Medical expects to launch the bronchoscope for clinical use on August 1 and will do a full commercial launch at a later day.
“At Pentax Medical we are committed to addressing the medical device hygiene challenges by continually innovating products, optimizing processes, and integrating feedback from the market. Our main objectives are to minimize the risk of infection, improve clinical outcomes, and enhance the professional’s experience and healthcare productivity within endoscopy. We are proud our portfolio now includes a single-use bronchoscope to enhance infection prevention without compromising on high-quality pulmonary care,” Rainer Burkard, Pentax Medical EMEA CEO and chief commercial officer of Americas, said.
